What is the best therapeutic approach to a pediatric patient with a deep-seated brain AVM?

Torstein R Meling1,2,3,4, Gildas Patet5

  • 1Department of Clinical Neurosciences, Division of Neurosurgery, Geneva University Hospitals, Geneva, Switzerland. torsteinrmeling@gmail.com.

Neurosurgical Review
|April 14, 2019
PubMed

Insights

Managing deep-seated pediatric brain arteriovenous malformations (bAVMs) is challenging. A multi-modal approach or active surveillance may be most suitable due to high complication risks.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Radiosurgery

Background:

  • Brain arteriovenous malformations (bAVMs) are rare in children but cause 50% of spontaneous intracranial hemorrhages.
  • Pediatric bAVMs exhibit higher rupture and recurrence rates than adult bAVMs, complicating management.
  • Treatment options include conservative care, microsurgery, endovascular therapy (EVT), gamma knife radiosurgery (GKRS), and proton-beam stereotactic radiosurgery (PSRS).

Purpose of the Study:

  • To systematically review and identify the optimal treatment approach for deep-seated pediatric bAVMs.
  • To evaluate the efficacy and complication rates of various treatment modalities for pediatric bAVMs.

Main Methods:

  • Systematic review conducted according to PRISMA guidelines.
  • Analysis of existing literature on treatment outcomes for pediatric bAVMs.

Main Results:

  • No single treatment modality offers a clear advantage when used alone.
  • Microsurgery has the highest obliteration rate but increased neurological complications.
  • EVT is effective as adjuvant therapy; standalone efficacy is low.
  • GKRS has low complication rates but suboptimal obliteration.
  • PSRS shows promise with precise radiation but has limited long-term data.

Conclusions:

  • A multi-modal treatment strategy or active surveillance is recommended for deep-seated pediatric bAVMs.
  • The complexity and high complication risk in pediatric patients necessitate individualized treatment planning.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
262
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K
Therapeutic Communication01:30

Therapeutic Communication

Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
7.8K